Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-17T20:16:44.406Z Has data issue: false hasContentIssue false

Ductal constriction during dexamethasone treatment in an anti-SSA-antibody-exposed fetus with signs of myocardial inflammation

Published online by Cambridge University Press:  18 April 2016

Lauren Talemal*
Affiliation:
Department of Cardiology, Children’s National Medical Center, Washington, District of Columbia, United States of America
Laura Olivieri
Affiliation:
Department of Cardiology, Children’s National Medical Center, Washington, District of Columbia, United States of America
Anita Krishnan
Affiliation:
Department of Cardiology, Children’s National Medical Center, Washington, District of Columbia, United States of America
*
Correspondence to: L. Talemal, Department of Cardiology, Children’s National Medical Center, 111 Michigan Avenue NW, Suite WW3-200, Washington, DC 20010, United States of America. Tel: +1 202 476 2020; Fax: +1 202 476 5700; E-mail: LTalemal@childrensnational.org

Abstract

This report describes the clinical course and multi-modality imaging findings in an anti-SSA-antibody-exposed fetus with suspected myocardial inflammation. Postnatal cardiac MRI – using fast acquisition, free-breathing with feed-and-swaddle technique – was used to evaluate for myocardial fibrosis/inflammation. This is the first published report, to our knowledge, of ductal constriction temporally associated with oral dexamethasone therapy in an anti-SSA-antibody-exposed fetus and of the use of this unique postnatal MRI protocol in this setting.

Type
Brief Reports
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Tham, E, Hung, R, Myers, K, et al. Optimization of myocardial nulling in pediatric cardiac MRI. Pediatr Radiol 2012; 42: 431439.Google Scholar
2. Krishnan, A, Pike, J, Donofrio, MT. Prenatal evaluation and management of fetuses exposed to anti-SSA/Ro antibodies. Pediatr Cardiol 2012; 33: 12451252.Google Scholar
3. Krishnan, A, Arya, B, Moak, J, Donofrio, MT. Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center. Prenat Diagn 2014; 34: 12071212.Google Scholar
4. Donofrio, MT, Moon-Grady, AJ, Hornberger, LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129: 21832428.Google Scholar
5. Nield, L, Silverman, E, Smallhorn, J, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002; 40: 796802.Google Scholar
6. Saleeb, S, Copel, J, Friedman, D, Buyon, JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 23352345.3.0.CO;2-3>CrossRefGoogle Scholar
7. Levy, R, Matitiau, A, Ben Arie, A, et al. Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. Am J Perinatol 1999; 16: 379383.Google Scholar
8. Takami, T, Momma, K, Imamura, S. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circulation 2005; 69: 354358.Google Scholar
9. Latus, H, Gummel, K, Klingel, K, et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson 2015; 17: 34.Google Scholar
10. Olivieri, LJ, Cross, RR, O’Brien, KE, et al. Free-breathing motion-corrected late-gadolinium-enhancement imaging improves image quality in children. Pediatr Radiol 2016 [Epub ahead of print].CrossRefGoogle ScholarPubMed